NCT06067620Not yet recruiting
Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy
Robotic Right Hemicolectomy With Intracorporeal Anastomosis Versus Laparoscopic Right Hemicolectomy With Extracorporeal Anastomosis (PRORHEM): a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 10 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Robotic right hemicolectomy with intra-corporeal anastomosis may have better short-term recovery outcomes and decreased incidence of incisional hernia when compared to the laparoscopic actual standard of care, for similar safety outcomes.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 11 Sept 2023
- Start date
- 1 Aug 2024
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- Jeremy Meyer
- Diseases
- Colorectal cancer
- NCT number
- NCT06067620
What you commit to
- Study type: Interventional
- Planned participants: 70
- From 1 Aug 2024 to the primary completion date, 1 Aug 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not scheduled for minimally invasive RHC (refuses surgery and/or planned open approach)
- Emergency surgery
- Synchronous resection of (an)other organ(s)
- Synchronous surgical procedure (including more extended resection of the lower gastrointestinal tract)
Other illness
- Hereditary colorectal cancer
- Inflammatory bowel disease
- History of laparotomy
Other
- cT4
- cM+
- Pregnancy
- No anastomosis planned
- Unable to provide informed consent
- No informed consent
Who the study is looking for
- Adult patients requiring elective minimally invasive RHC for cT1-T3 Nx M0 cancer of the right colon (including cancer of the appendix, caecum, ascending colon and hepatic flexure).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.